PALISADE CAPITAL MANAGEMENT, LP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 43 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$237,405
+1.5%
238,0000.0%0.01%0.0%
Q4 2022$233,835
+0.8%
238,0000.0%0.01%
-14.3%
Q3 2022$232,000
+0.4%
238,0000.0%0.01%
+16.7%
Q2 2022$231,000
-82.6%
238,000
-82.2%
0.01%
-80.6%
Q1 2022$1,331,000
+5.1%
1,338,000
+4.6%
0.03%
+19.2%
Q4 2021$1,267,000
+12.4%
1,279,000
+11.7%
0.03%
+4.0%
Q3 2021$1,127,000
+2461.4%
1,145,000
+2444.4%
0.02%
+2400.0%
Q2 2021$44,000
+214.3%
45,000
+200.0%
0.00%
Q1 2021$14,00015,0000.00%
Other shareholders

There were no reported owners of SUPERNUS PHARMACEUTICALS INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders